Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers

Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers

Prostate cancer (PCa), bladder cancer (BCa), and renal cell carcinoma (RCC) are the most common urological cancers, and their incidence has been rising over time. Surgery is the standard treatment for these cancers, but this procedure is only effective when the disease is localized. For metastatic d...

Full description

Bibliographic Details
Main Authors: Filipa Amaro, Márcia Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho, Joana Pinto
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Pharmaceuticals
Subjects:
prostate cancer
bladder cancer
renal cell carcinoma
pharmacometabolomics
biomarkers
treatment response
Online Access:https://www.mdpi.com/1424-8247/15/3/295

Internet

https://www.mdpi.com/1424-8247/15/3/295

Similar Items